← Back to Patent Explorer
US4125599A Expired / Lapsed US ⏱️ 0.0 years remaining

X-ray contrast agents

Assignee: Mallinckrodt Inc
•
Filing: 1976-08-19
•
Granted: 1978-11-14
•
Expires: 1996-08-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 5-Gluconamido-2,4,6-triiodo-N-methylisophthalamic acid, 3-acetamido-2,4,6-triiodo-5-trishydroxymethylacetamidobenzoic acid, related compounds and salts and esters thereof are useful as x-ray contrast agents. The corresponding acyl halides are useful as intermediates.

Inventors

  • 👤 Philip E. Wiegert

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:43
CPC Classifications
C; C07; C07C; C07C233/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 46 words
A compound of the formula: ##STR15## wherein X is selected from the group consisting of lower acylamino, N-(lower alkyl)-lower acylamino, N-(hydroxy lower alkyl)-lower acylamino, carbamyl and N-(lower alkyl) carbamyl and Y is gluconamido, and salts thereof with pharmaceutically acceptable cations, and esters thereof with lower alkanols.
Claim 2
Dependent Claim 46 words
A compound of the formula: ##STR15## wherein X is selected from the group consisting of lower acylamino, N-(lower alkyl)-lower acylamino, N-(hydroxy lower alkyl)-lower acylamino, carbamyl and N-(lower alkyl) carbamyl and Y is gluconamido, and salts thereof with pharmaceutically acceptable cations, and esters thereof with lower alkanols.
Claim 3
Dependent Claim 11 words
A compound as defined by claim 1 which is 5-gluconamido-2,4,6-triiodo-N-methylisophthalamic acid.
Claim 4
Dependent Claim 19 words
A compound as defined by claim 1 which is a salt of 5-gluconamido-2,4,6-triiodo-N-methylisophthalamic acid with a pharmaceutically acceptable cation.
Claim 5
Dependent Claim 14 words
A compound as defined by claim 3 wherein the pharmaceutically acceptable cation is sodium.
Claim 6
Dependent Claim 14 words
A compound as defined by claim 3 wherein the pharmaceutically acceptable cation is N-methylglucamine.
Claim 7
Dependent Claim 56 words
An x-ray contrast medium comprising an aqueous solution of an effective amount of a salt of a compound of the formula: ##STR16## wherein X is selected from the group consisting of lower acylamino, N-(lower alkyl)-lower acylamino, N-(hydroxy lower alkyl)-lower acylamino, carbamyl and N-(lower alkyl) carbamyl and Y is gluconamido, with at least one pharmaceutically acceptable cation.
Claim 8
Dependent Claim 56 words
An x-ray contrast medium comprising an aqueous solution of an effective amount of a salt of a compound of the formula: ##STR16## wherein X is selected from the group consisting of lower acylamino, N-(lower alkyl)-lower acylamino, N-(hydroxy lower alkyl)-lower acylamino, carbamyl and N-(lower alkyl) carbamyl and Y is gluconamido, with at least one pharmaceutically acceptable cation.
Claim 9
Dependent Claim 15 words
An x-ray contrast medium as defined by claim 6 wherein said compound is 5-gluconamido-2,4,6-triiodo-N-methylisophthalamic acid.

References Cited (Backward Citations)

US3145197A Cited
US3622616A Cited
US3702866A Cited
US3701771A Cited
US4021481A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-11-13 1982-05-15 1982-11-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-11-13 1986-05-15 1986-11-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-11-13 1990-05-15 1990-11-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag